Literature DB >> 24427359

Comparison of cutaneous sarcoidosis with systemic sarcoidosis: a retrospective analysis.

Chunguang Tong1, Xiuying Zhang1, Jie Dong1, Yanling He1.   

Abstract

OBJECTIVE: To investigate clinical characteristics and treatment effect of sarcoidosis with cutaneous lesions in Chinese patients, and to compare them with previous works.
METHODS: Retrospective analysis was conducted based on clinical manifestations, systemic examinations and treatment of biopsy-proved 36 patients with sarcoidosis with cutaneous lesions in our hospital since 2000. Patients were divided into cutaneous sarcoidosis (CS) group without systemic involvement and systemic sarcoidosis (SS) group with systemic involvement according to whether extracutaneous systems were involved.
RESULTS: Male to female ratio was 1:4.1 in total 36 patients. Average age of onset was (43.6±15.8) years old in CS group and (54.4±11.5) years old in SS group. The most common cutaneous lesions were papulonodules (41.7%) and frequently found in limbs (61.1%). There were 26 patients in SS group, and lung was the most common organ with systemic involvement, followed by lymph nodes. In SS group, elevation of inflammatory parameters and evident changes of chest radiologic examination were often observed. 72.2% patients were treated with glucocorticoid and the overall therapeutic efficacy rate was 48.4%. The therapeutic efficacy in CS group (80%) was significantly higher than SS group (33.3%). Papulonodules type had better response to therapy and usually resolved after treatment. Lupus pernio type was resistant to treatment.
CONCLUSION: Sarcoidosis occurs more frequently in females. Lung is the most commonly affected extracutaneous organ in SS patients. CS patients have better response to therapy than SS patients. Types of cutaneous lesions and existence of systemic involvement are related to prognosis of cutaneous lesions.

Entities:  

Keywords:  Cutaneous sarcoidosis; prognosis; systemic sarcoidosis

Mesh:

Year:  2013        PMID: 24427359      PMCID: PMC3885493     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

Review 1.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

Review 2.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

3.  The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy.

Authors:  Elliott D Crouser; Gerard Lozanski; Charity C Fox; David W Hauswirth; Rekha Raveendran; Mark W Julian
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

4.  Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore.

Authors:  W-S Chong; H-H Tan; S-H Tan
Journal:  Clin Exp Dermatol       Date:  2005-03       Impact factor: 3.470

5.  Sarcoidosis of the thyroid and kidneys and calcium metabolism.

Authors:  Om P Sharma; Violeta Vucinić
Journal:  Semin Respir Crit Care Med       Date:  2002-12       Impact factor: 3.119

6.  Clinical characteristics of patients in a case control study of sarcoidosis.

Authors:  R P Baughman; A S Teirstein; M A Judson; M D Rossman; H Yeager; E A Bresnitz; L DePalo; G Hunninghake; M C Iannuzzi; C J Johns; G McLennan; D R Moller; L S Newman; D L Rabin; C Rose; B Rybicki; S E Weinberger; M L Terrin; G L Knatterud; R Cherniak
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

7.  Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease.

Authors:  J Marcoval; J Mañá; M Rubio
Journal:  Clin Exp Dermatol       Date:  2011-07-25       Impact factor: 3.470

Review 8.  Extrapulmonary sarcoidosis.

Authors:  Marc A Judson
Journal:  Semin Respir Crit Care Med       Date:  2007-02       Impact factor: 3.119

Review 9.  Targeting the TNF-alpha pathway in sarcoidosis.

Authors:  Sabina A Antoniu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

10.  Cutaneous sarcoidosis: a histopathological study.

Authors:  J C Cardoso; M Cravo; J P Reis; O Tellechea
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-02-26       Impact factor: 6.166

View more
  5 in total

1.  An Adolescent with Extensive Cutaneous Sarcoidosis without Lung Involvement.

Authors:  Pravakar Mishra; Subhankar Mishra; Sunil K Agarwalla; Niranjan Mohanty; Rashmi Ranjan Das
Journal:  Indian J Pediatr       Date:  2017-02-18       Impact factor: 1.967

2.  Epidemiology of cutaneous sarcoidosis, 1976-2013: a population-based study from Olmsted County, Minnesota.

Authors:  P Ungprasert; D A Wetter; C S Crowson; E L Matteson
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-06-21       Impact factor: 6.166

3.  Cutaneous Sarcoidosis: A Retrospective Clinico-Pathological Study from the Indian Subcontinent in Patients Attending a Tertiary Health Care Centre.

Authors:  Gauri D Mahabal; Dincy C V Peter; Leni George; Meera Thomas; Susanne A Pulimood
Journal:  Indian Dermatol Online J       Date:  2021-07-14

4.  Scar Sarcoidosis: A Retrospective Investigation into Its Peculiar Clinicopathologic Presentation.

Authors:  Kyung-Nam Bae; Kihyuk Shin; Hoon-Soo Kim; Hyun-Chang Ko; Byungsoo Kim; Moon-Bum Kim
Journal:  Ann Dermatol       Date:  2022-01-27       Impact factor: 1.444

5.  Prevalence and characteristics of cutaneous sarcoidosis in Argentina.

Authors:  Marina Abed Dickson; Bárbara Agustina Hernández; Sebastian Marciano; Luis Daniel Mazzuoccolo
Journal:  Int J Womens Dermatol       Date:  2021-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.